MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET 2023-2030

Triton’s research report insinuates that the male infertility market in the Middle East and Africa is estimated to progress with a CAGR of 5.02% during the forecasting years 2023-2030.

Report scope can be customized per your requirements - Request Free Sample Report

The countries assessed in the region comprise:

• United Arab Emirates

• Saudi Arabia

• Turkey

• South Africa

• Rest of Middle East & Africa

The Middle East and Africa is witnessing an increase in infertility rates, medical and fertility tourism, and the prevalence of diseases like cancer and diabetes. These factors are anticipated to drive the adoption of assisted reproductive technology (ART) surgeries, thereby supporting the expansion of the male infertility market across the region’s nations over the forecast period.

Turkey captures the majority share in the male infertility market. The nation's market is anticipated to grow substantially due to the increasing prevalence of diseases such as diabetes and cancer. According to the International Diabetes Federation, the number of people with diabetes in Turkey reached around 9 million in 2020. By 2030 and 2045, these numbers are projected to increase to 10.8 billion and 13.3 billion, respectively. The escalating prevalence of diabetes is expected to harm male fertility, thus driving the demand for infertility treatments.

Furthermore, Turkey has emerged as a popular destination for medical tourism, attracting patients from Europe and the Middle East due to its high-quality and cost-effective healthcare services. The country’s expanding healthcare facilities offer significant growth opportunities to the male infertility market.

Further, the male infertility market in the United Arab Emirates is expected to grow due to various factors, such as declining fertility rates, the expansion of fertility centers, and supportive government policies. Fertility rates across the nation have declined substantially by 0.94% since 2021. This decline in fertility rates has increased demand for both diagnosis and treatment to improve nationwide conception rates.

Oxidative stress significantly impacts male infertility and normal embryonic development. As a result, there is an increased focus on analyzing oxidative stress and researching methods to diagnose and treat infertility using antioxidants. As per the National Institutes of Health, around 30% to 80% of infertile men have higher levels of reactive oxygen species (ROS) in their seminal fluid. The harmful effects of oxidative stress on fertility are manifested through various mechanisms, including interference with capacitation and damage to DNA and sperm membranes. Hence, evaluating sperm oxidative stress is crucial when assessing male reproductive potential.

The market’s growth is determined based on test type and treatment. The test type is further sectioned into oxidative stress analysis, computer-assisted semen analysis, sperm penetration assay, DNA fragmentation technique, microscopic examination, sperm agglutination, and other test types.

The notable companies in the market include Vitrolife, Bayer AG, Aytu BioPharma, Zydus Lifesciences Limited, and CinnaGen Co.

CinnaGen Co is among the largest biopharmaceutical manufacturers and biotech exporters in the Middle East. Specializing in biotechnology and related industries, it focuses on developing cutting-edge biosimilar candidates for infertility, immunological illnesses, diabetes, kidney diseases, osteoporosis, and hormonal disorders. Approximately 20% of its revenue is dedicated to research and development (R&D) efforts. Its product line includes PCR kits, enzymes, and molecular biology supplies. The operates across multiple regions, with headquarters based in Iran.

Key deliverables of the report:

● Market CAGR during the forecasting years 2023-2030

● Detailed data highlighting key insights, industry components, and market strategies

● Comprehensive information and estimation of the male infertility market revenue growth in the Middle East and Africa and its influence on the parent market

● In-depth study of forthcoming trends in consumer behavioral patterns

● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

● A wide-ranging study of factors that will challenge the Middle East and Africa male infertility market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.

Major Players in the Market

Related Reports

Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT

Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2022-2028

Market by Therapeutics, Diagno ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. PARENT MARKET ANALYSIS

2.2. IMPACT ANALYSIS ON THE MALE INFERTILITY MARKET

2.2.1. COVID-19 IMPACT

2.2.2. UKRAINE-RUSSIA WAR IMPACT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET MATURITY ANALYSIS

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. MERGERS & ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. PREVALENCE OF INFERTILITY

2.6.2. USE OF ASSISTED REPRODUCTIVE TECHNOLOGIES

2.6.3. TECHNOLOGICAL INNOVATIONS AND ADVANCEMENTS

2.7. MARKET CHALLENGE

2.7.1. HIGH COST OF TREATMENT

2.8. MARKET OPPORTUNITIES

2.8.1. INCREASING ACCEPTANCE OF MINIMALLY INVASIVE SURGERIES

2.8.2. GROWING AVAILABILITY OF INFERTILITY TREATMENT DRUGS, PROCEDURES, AND DEVICES

2.8.3. GOVERNMENT INITIATIVES TOWARD IMPROVING REIMBURSEMENT POLICIES

2.9. ANALYST PERSPECTIVE

3. MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET – BY TEST TYPE

3.1. DNA FRAGMENTATION TECHNIQUE

3.2. OXIDATIVE STRESS ANALYSIS

3.3. MICROSCOPIC EXAMINATION

3.4. SPERM AGGLUTINATION

3.5. COMPUTER-ASSISTED SEMEN ANALYSIS

3.6. SPERM PENETRATION ASSAY

3.7. OTHER TEST TYPES

4. MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET – BY TREATMENT

4.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY

4.2. MEDICATIONS

5. MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET – BY COUNTRY OUTLOOK

5.1. COUNTRY ANALYSIS

5.1.1. UNITED ARAB EMIRATES

5.1.1.1. UNITED ARAB EMIRATES MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.2. TURKEY

5.1.2.1. TURKEY MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.3. SAUDI ARABIA

5.1.3.1. SAUDI ARABIA MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.4. SOUTH AFRICA

5.1.4.1. SOUTH AFRICA MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.5. REST OF MIDDLE EAST & AFRICA

5.1.5.1. REST OF MIDDLE EAST & AFRICA MALE INFERTILITY MARKET FORECAST & PROSPECTS

6. COMPETITIVE LANDSCAPE

6.1. HALOTECH DNA

6.1.1. OVERVIEW

6.1.2. PRODUCT PORTFOLIO

6.2. EMD SERONO INC

6.2.1. OVERVIEW

6.2.2. PRODUCT PORTFOLIO

6.2.3. KEY STRENGTHS

6.2.4. KEY CHALLENGES

6.3. ENDO INTERNATIONAL PLC

6.3.1. OVERVIEW

6.3.2. PRODUCT PORTFOLIO

6.3.3. KEY STRENGTHS

6.3.4. KEY CHALLENGES

6.4. VITROLIFE

6.4.1. OVERVIEW

6.4.2. PRODUCT PORTFOLIO

6.4.3. KEY STRENGTHS

6.4.4. KEY CHALLENGES

6.5. BAYER AG

6.5.1. OVERVIEW

6.5.2. PRODUCT PORTFOLIO

6.5.3. KEY STRENGTHS

6.5.4. KEY CHALLENGES

6.6. AYTU BIOPHARMA

6.6.1. OVERVIEW

6.6.2. PRODUCT PORTFOLIO

6.6.3. KEY STRENGTHS

6.6.4. KEY CHALLENGES

6.7. ZYDUS LIFESCIENCES LIMITED

6.7.1. OVERVIEW

6.7.2. PRODUCT PORTFOLIO

6.7.3. KEY STRENGTHS

6.7.4. KEY CHALLENGES

6.8. CINNAGEN CO

6.8.1. OVERVIEW

6.8.2. PRODUCT PORTFOLIO

6.8.3. KEY STRENGTHS

6.8.4. KEY CHALLENGES

6.9. SANOFI SA

6.9.1. OVERVIEW

6.9.2. PRODUCT PORTFOLIO

6.9.3. KEY STRENGTHS

6.9.4. KEY CHALLENGES

6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS

6.10.1. OVERVIEW

6.10.2. PRODUCT PORTFOLIO

6.10.3. KEY STRENGTHS

6.10.4. KEY CHALLENGES

7. RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: LIST OF COLLABORATIONS

TABLE 3: LIST OF PRODUCT LAUNCHES

TABLE 4: LIST OF MERGERS & ACQUISITIONS

TABLE 5: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 6: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)

TABLE 7: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)

TABLE 8: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET MATURITY ANALYSIS

FIGURE 2: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY TYPE, 2022 & 2030 (IN %)

FIGURE 3: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)

FIGURE 4: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 5: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2030 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2030 (IN $ MILLION)

FIGURE 7: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2030 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2030 (IN $ MILLION)

FIGURE 10: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY TREATMENT, 2022 & 2030 (IN %)

FIGURE 11: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2030 (IN $ MILLION)

FIGURE 12: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: UNITED ARAB EMIRATES MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: TURKEY MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 16: SAUDI ARABIA MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 17: SOUTH AFRICA MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 18: REST OF MIDDLE EAST & AFRICA MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)